Contraception

Last reviewed: 30 Nov 2025
Last updated: 02 Oct 2025

Summary

Details

  • Initial counseling
  • Barrier methods
  • Barrier methods: the diaphragm and cervical cap
  • Barrier methods: the female condom
  • Barrier methods: the male condom
  • Barrier methods: spermicide
  • Behavioral methods
  • Behavioral methods: lactational amenorrhea
  • Behavioral methods: periodic abstinence
  • Behavioral methods: withdrawal
  • Hormonal contraception
  • Combined hormonal contraceptives (estrogen/progestogen)
  • Contraindications to estrogen-containing contraceptives
  • Combined hormonal contraceptives: estrogen/progestogen pills
  • Combined hormonal contraceptives: estrogen/progestogen patch
  • Combined hormonal contraceptives: estrogen/progestogen vaginal ring
  • Progestogen-only contraceptives
  • Progestogen-only contraceptives: progestogen-only pill
  • Progestogen-only contraceptives: progestogen implant
  • Progestogen-only contraceptives: progestogen injection
  • Non-hormonal contraception
  • Intrauterine devices (IUDs)
  • Intrauterine devices: copper IUD
  • Intrauterine devices: progestogen IUD
  • Sterilization
  • Sterilization: female sterilization
  • Sterilization: male sterilization
  • Non-contraceptive benefits of hormonal contraceptives
  • Emergency contraception
  • Emergency contraception: progestogen-only emergency contraception
  • Emergency contraception: ulipristal
  • Emergency contraception: copper IUD
  • Emergency contraception: estrogen/progestogen emergency contraception
  • Guidelines
Todos los datos

Colaboradores

Autores

Anne Burke, MD, MPH

Associate Professor

Johns Hopkins University

Baltimore

MD

Divulgaciones

AB has received research support from Merck and Chemo.

Agradecimientos

Dr Anne Burke would like to gratefully acknowledge Dr Ruth Lesnewski, a previous contributor to this topic.

Divulgaciones

RL declares that she has no competing interests.

Revisores por pares

Larry Leeman, MD, MPH

Associate Professor of Family and Community Medicine

Associate Professor of Obstetrics and Gynecology

Family Medicine Department

University of New Mexico

Albuquerque

NM

Divulgaciones

LL declares that he has no competing interests.

Suzan Goodman, MD, MPH

Director

TEACH Program

Assistant Clinical Professor

UCSF and UCD

San Francisco

CA

Divulgaciones

SG has served as an Implanon training specialist for Organon Inc.

Lesley Bacon, FFSRH, MRCGP

Consultant in Sexual and Reproductive Health

Lewisham Primary Care Trust

Waldron Health Centre

London

UK

Divulgaciones

LB was a member of the group that produced the 2006 Faculty of Sexual and Reproductive Health guidance on the management of women with vaginal discharge presenting in a non-genitourinary settings.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Curtis KM, Nguyen AT, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2024. MMWR Recomm Rep 2024;73(3):1-77.Texto completo  Resumen

The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. UK Medical Eligibility Criteria for contraceptive use (UKMEC). Sep 2019 [internet publication].Texto completo

World Health Organization. Medical Eligibility Criteria for contraceptive use (MEC). Fifth edition. Aug 2015 [internet publication].Texto completo  Resumen

Nguyen AT, Curtis KM, Tepper NK, et al. U.S. medical eligibility criteria for contraceptive use, 2024. MMWR Recomm Rep 2024;73(4):1-126.Texto completo  Resumen

Stewart FH, Harper CC, Ellertson CE, et al. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA. 2001 May 2;285(17):2232-9. Resumen

American College of Obstetricians and Gynecologists. Practice bulletin no. 186 summary: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2017 Nov;130(5):1173-5. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad